Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Catenacci DV, Cervantes G, Yala S, Nelson EA, El-Hashani E, Kanteti R, El Dinali M, Hasina R, Brägelmann J, Seiwert T, Sanicola M, Henderson L, Grushko TA, Olopade O, Karrison T, Bang YJ, Kim WH, Tretiakova M, Vokes E, Frank DA, Kindler HL, Huet H, Salgia R.

Cancer Biol Ther. 2011 Jul 1;12(1):9-46. doi: 10.4161/cbt.12.1.15747. Epub 2011 Jul 1.

2.

An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours.

Kelly RK, Olson DL, Sun Y, Wen D, Wortham KA, Antognetti G, Cheung AE, Orozco OE, Yang L, Bailly V, Sanicola M.

Eur J Cancer. 2011 Jul;47(11):1736-46. doi: 10.1016/j.ejca.2011.02.023. Epub 2011 Mar 31.

PMID:
21458984
3.

CRIPTO3, a presumed pseudogene, is expressed in cancer.

Sun C, Orozco O, Olson DL, Choi E, Garber E, Tizard R, Szak S, Sanicola M, Carulli JP.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):215-20. doi: 10.1016/j.bbrc.2008.09.113. Epub 2008 Oct 1.

PMID:
18835250
4.

Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration.

Watanabe K, Bianco C, Strizzi L, Hamada S, Mancino M, Bailly V, Mo W, Wen D, Miatkowski K, Gonzales M, Sanicola M, Seno M, Salomon DS.

J Biol Chem. 2007 Oct 26;282(43):31643-55. Epub 2007 Aug 24.

5.

Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.

Wechselberger C, Strizzi L, Kenney N, Hirota M, Sun Y, Ebert A, Orozco O, Bianco C, Khan NI, Wallace-Jones B, Normanno N, Adkins H, Sanicola M, Salomon DS.

Oncogene. 2005 Jun 9;24(25):4094-105.

PMID:
15897912
6.

Role of human cripto-1 in tumor angiogenesis.

Bianco C, Strizzi L, Ebert A, Chang C, Rehman A, Normanno N, Guedez L, Salloum R, Ginsburg E, Sun Y, Khan N, Hirota M, Wallace-Jones B, Wechselberger C, Vonderhaar BK, Tosato G, Stetler-Stevenson WG, Sanicola M, Salomon DS.

J Natl Cancer Inst. 2005 Jan 19;97(2):132-41.

PMID:
15657343
7.

Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.

Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y, Sanicola M, Salomon DS.

J Cell Physiol. 2004 Nov;201(2):266-76.

PMID:
15334661
8.

Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.

Kenney NJ, Adkins HB, Sanicola M.

J Mammary Gland Biol Neoplasia. 2004 Apr;9(2):133-44. Review.

PMID:
15300009
9.

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.

Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L, Sanicola M, Salomon DS.

J Cell Physiol. 2004 Jan;198(1):31-9.

PMID:
14584041
10.

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.

Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M.

J Clin Invest. 2003 Aug;112(4):575-87.

11.

The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.

Foley SF, van Vlijmen HW, Boynton RE, Adkins HB, Cheung AE, Singh J, Sanicola M, Young CN, Wen D.

Eur J Biochem. 2003 Sep;270(17):3610-8.

12.

A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.

Bianco C, Strizzi L, Rehman A, Normanno N, Wechselberger C, Sun Y, Khan N, Hirota M, Adkins H, Williams K, Margolis RU, Sanicola M, Salomon DS.

Cancer Res. 2003 Mar 15;63(6):1192-7. Erratum in: Cancer Res. 2003 Apr 15;63(8):1997.

13.

Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration.

Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV.

J Biol Chem. 2002 Oct 18;277(42):39739-48. Epub 2002 Jul 23.

14.

Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.

Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Ebert A, Williams KP, Sanicola M, Salomon DS.

Mol Cell Biol. 2002 Apr;22(8):2586-97.

15.

Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.

Bianco C, Normanno N, De Luca A, Maiello MR, Wechselberger C, Sun Y, Khan N, Adkins H, Sanicola M, Vonderhaar B, Cohen B, Seno M, Salomon D.

J Cell Physiol. 2002 Jan;190(1):74-82.

PMID:
11807813
16.

Fucosylation of Cripto is required for its ability to facilitate nodal signaling.

Schiffer SG, Foley S, Kaffashan A, Hronowski X, Zichittella AE, Yeo CY, Miatkowski K, Adkins HB, Damon B, Whitman M, Salomon D, Sanicola M, Williams KP.

J Biol Chem. 2001 Oct 12;276(41):37769-78. Epub 2001 Aug 10.

17.

GFRalpha3 is expressed predominantly in nociceptive sensory neurons.

Orozco OE, Walus L, Sah DW, Pepinsky RB, Sanicola M.

Eur J Neurosci. 2001 Jun;13(11):2177-82.

PMID:
11422460
18.

The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.

Saloman DS, Bianco C, Ebert AD, Khan NI, De Santis M, Normanno N, Wechselberger C, Seno M, Williams K, Sanicola M, Foley S, Gullick WJ, Persico G.

Endocr Relat Cancer. 2000 Dec;7(4):199-226. Review.

PMID:
11174844
19.

Developmental regulation of GDNF response and receptor expression in the enteric nervous system.

Worley DS, Pisano JM, Choi ED, Walus L, Hession CA, Cate RL, Sanicola M, Birren SJ.

Development. 2000 Oct;127(20):4383-93.

20.

Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

George J, Wang SS, Sevcsik AM, Sanicola M, Cate RL, Koteliansky VE, Bissell DM.

Am J Pathol. 2000 Jan;156(1):115-24.

21.

Perturbation of RET signaling in the embryonic kidney.

Ehrenfels CW, Carmillo PJ, Orozco O, Cate RL, Sanicola M.

Dev Genet. 1999;24(3-4):263-72.

PMID:
10322634
22.
23.

Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M.

J Biol Chem. 1998 Feb 13;273(7):4135-42.

24.

Genomic structure and chromosomal localization of the human GDNFR-alpha gene.

Eng C, Myers SM, Kogon MD, Sanicola M, Hession C, Cate RL, Mulligan LM.

Oncogene. 1998 Feb 5;16(5):597-601.

25.

Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins.

Sanicola M, Hession C, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, Whitty A, Pepinsky RB, Cate RL.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6238-43.

26.

Molecular evolution at the decapentaplegic locus in Drosophila.

Newfeld SJ, Padgett RW, Findley SD, Richter BG, Sanicola M, de Cuevas M, Gelbart WM.

Genetics. 1997 Feb;145(2):297-309.

27.
28.

FLP-mediated intermolecular recombination in the cytoplasm of Drosophila embryos.

Konsolaki M, Sanicola M, Kozlova T, Liu V, ArcĂ  B, Savakis C, Gelbart WM, Kafatos FC.

New Biol. 1992 May;4(5):551-7.

PMID:
1381216
30.
31.
32.

Molecular characterization of the histone gene family of Caenorhabditis elegans.

Roberts SB, Sanicola M, Emmons SW, Childs G.

J Mol Biol. 1987 Jul 5;196(1):27-38.

PMID:
3656446

Supplemental Content

Loading ...
Support Center